Erythro-9-[2-hydroxyl-3-nonyl]-adenine Reduces Intestinal Permeability and Improves Survival in Sepsis
Author Information
Author(s): Kayhan Nalan, Funke Benjamin, Conzelmann Lars Oliver, Winkler Harald, Hofer Stefan, Steppan Jochen, Schmidt Heinfried, Bardenheuer Hubert, Vahl Christian-Friedrich, Weigand Markus A
Primary Institution: University of Mainz
Hypothesis
Can adenosine deaminase-1 and cyclic guanosine monophosphate-stimulated phosphodiesterase inhibition by erythro-9-[2-hydroxyl-3-nonyl]-adenine be beneficial in experimental endotoxicosis/sepsis?
Conclusion
Erythro-9-[2-hydroxyl-3-nonyl]-adenine shows beneficial effects in reducing intestinal permeability and improving survival rates in sepsis models.
Supporting Evidence
- Erythro-9-[2-hydroxyl-3-nonyl]-adenine treatment improved survival rates in septic shock models.
- Intestinal permeability was significantly reduced in treated animals compared to controls.
- Histological analysis showed normal mucosal architecture in treated animals.
Takeaway
A special medicine helped sick rats with sepsis feel better and live longer by fixing their intestines.
Methodology
The study used two animal models: endotoxicosis in rats and sepsis in mice, with treatments administered via intravenous infusion and injections.
Potential Biases
Potential bias in animal model selection and treatment administration.
Limitations
The study is based on animal models, which may not fully replicate human sepsis conditions.
Participant Demographics
Twenty-four male Wistar rats and eighty-four female C57BL/6 mice were used in the study.
Statistical Information
P-Value
p = 0.0018
Statistical Significance
p < 0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website